Article info
Clinical ethics
Response
The ethics of placebo treatments in clinical practice: a reply to Glackin
- Correspondence to Dr Anne Barnhill, Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, PA 19104, USA; anne.barnhill{at}gmail.com
Citation
The ethics of placebo treatments in clinical practice: a reply to Glackin
Publication history
- Received December 23, 2014
- Revised May 11, 2015
- Accepted May 25, 2015
- First published June 22, 2015.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Patients’ attitudes about the use of placebo treatments: telephone survey
- Physician perspectives on placebo ethics
- The ethics of the placebo in clinical practice revisited
- Parsing placebo treatments: a response to Barnhill and Miller
- Placebo: the lie that comes true?
- Patient attitudes about the clinical use of placebo: qualitative perspectives from a telephone survey
- Prescribing “placebo treatments”: results of national survey of US internists and rheumatologists
- What do we really know about the deliberate use of placebos in clinical practice?
- The moral case for the clinical placebo
- Informed consent and clinical trials: where is the placebo effect?